NCT05828459 2025-03-20First-in-human Study of OT-A201 in Patients With Selected Hematological Malignancies and Solid TumorsOnward TherapeuticsPhase 1 Recruiting150 enrolled
NCT01351350 2019-08-08Dose Escalation Study of MLN0128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid MalignanciesTakedaPhase 1 Completed68 enrolled 29 charts